TM4SF19 rs11919443: Understanding Your Genetic Variant
The rs11919443 variant is a genetic change located within the TM4SF19 gene. Research has associated this variant with distinct patterns of systemic inflammation, specifically involving IL-17A, in patients experiencing critical illness following trauma.
What each genotype means
Elevated IL-17A response
Research in critically ill trauma patients indicates that individuals with this genotype may exhibit higher circulating levels of the inflammatory mediator IL-17A. This profile has been associated with longer stays in the intensive care unit and a greater requirement for mechanical ventilation compared to those with the BB genotype. If you are facing a medical situation, please discuss these findings with your clinician to understand how they may relate to your specific health context.
This genotype is found in approximately 5-10% of trauma cohorts, though exact frequencies in the general population may vary.
Lower IL-17A response
Studies of critically ill trauma patients suggest that individuals with this genotype tend to have lower circulating levels of IL-17A compared to those with the AA genotype. This group has been observed to have shorter intensive care unit stays and reduced requirements for mechanical ventilation in clinical research settings. Please consult with your healthcare provider to discuss how your genetic profile might be relevant to your personal health management.
This genotype is found in approximately 5-10% of trauma cohorts, though exact frequencies in the general population may vary.
Intermediate inflammatory profile
This genotype represents the heterozygous state for the rs11919443 variant. While research has highlighted distinct clinical and inflammatory differences between the homozygous AA and BB groups, specific data regarding the intermediate clinical outcomes for the AB genotype is less characterized in current literature. You should discuss any concerns regarding your health or inflammatory response with your physician.
This genotype is common in the general population, appearing in the majority of individuals within the studied trauma cohorts.
What is rs11919443?
The rs11919443 variant is a single-nucleotide polymorphism (SNP) located within the TM4SF19 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as an intronic SNP, meaning it resides within a non-coding region of the gene. While it does not directly alter the protein sequence produced by the gene, such variants can influence how genes are regulated or expressed. Current research identifies this variant as a non-hub SNP, meaning it is not a central regulator in the complex networks of gene interactions, yet it remains a point of interest for its observed statistical associations with inflammatory responses in specific clinical contexts.
The Role of the TM4SF19 Gene
The TM4SF19 gene encodes a member of the tetraspanin family of proteins. Tetraspanins are known to organize other proteins on the cell surface, facilitating various cellular processes including signaling, adhesion, and migration. Recent studies have highlighted the role of TM4SF19 in immune and bone-related functions. Specifically, research has shown that TM4SF19 is expressed in macrophages and osteoclasts, cells involved in inflammation and bone remodeling, respectively. By interacting with other cellular components, such as integrins, TM4SF19 helps regulate signaling pathways that can influence inflammatory responses. Understanding this gene's function provides context for why variations within it might be linked to differences in how the body manages inflammation during severe stress or injury.
Research and Evidence
The evidence linking rs11919443 to health outcomes is currently considered moderate and is primarily derived from studies on critically ill trauma patients. Research has observed that individuals with different genotypes at this SNP exhibit distinct trajectories of systemic inflammatory mediators, most notably IL-17A, following a traumatic injury. IL-17A is a cytokine that plays a significant role in immune responses. Some studies have suggested that specific homozygous genotypes at this locus are associated with variations in the intensity of the inflammatory response and clinical outcomes, such as the length of stay in an intensive care unit. It is important to note that these findings are based on specific cohorts of trauma patients. As with many genetic associations, these results require further validation in larger, more diverse populations to fully understand the clinical implications.
Interpreting Your Information
Genetic information regarding variants like rs11919443 is intended for educational purposes and should not be used for medical diagnosis or to predict individual health outcomes. The associations observed in research studies are statistical trends seen across groups of people, not definitive rules for any single individual. Many factors, including environment, lifestyle, and other genetic markers, contribute to how a person responds to illness or injury. If you have concerns about your health or how your genetic profile might influence your medical care, it is essential to discuss this information with a qualified healthcare provider or a genetic counselor. They can help you interpret these findings in the context of your overall health history and provide appropriate guidance.
How common is this variant?
In studies of critically ill trauma cohorts, this variant has been identified in approximately 5-10% of patients.
Frequently asked questions
What does rs11919443 do?
The rs11919443 variant is a genetic marker associated with differences in how the body regulates systemic inflammation, particularly IL-17A, in the context of severe trauma.
Is rs11919443 a disease-causing mutation?
No, it is not classified as a disease-causing mutation. It is a genetic variant associated with statistical differences in inflammatory responses within specific clinical populations.
Should I be worried if I have this variant?
Genetic variants are common, and having a specific genotype does not mean you will experience a particular health outcome. You should consult with a healthcare professional to discuss any concerns regarding your genetic results.
Can I change my risk associated with this SNP?
Genetic variants are inherited and cannot be changed. However, understanding your health risks allows you to work with your doctor to manage your overall health through lifestyle and medical care.
Sources & further reading
Educational information only, last refreshed 10/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11919443?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29